Poloxamer 338 (P338), a nonionic surfactant amphiphilic copolymer, is herein proposed as an anti-biofilm compound for the management of catheter-associated urinary tract infections (CAUTIs). P338’s ability to disrupt Escherichia coli biofilms on silicone urinary catheters and to serve as antibiotic enhancer was evaluated for biofilm-producing E. coli Ec5FSL and Ec9FSL clinical strains, isolated from urinary catheters. In static conditions, quantitative biofilm formation assay allowed us to determine the active P338 concentration. In dynamic conditions, the BioFlux system, combined with confocal laser scanning microscopy, allowed us to investigate the P338 solution’s ability to detach biofilm, alone or in combination with sub-MIC concentrations of cefoxitin (FOX). The 0.5% P338 solution was able to destroy the structure of E. coli biofilms, to reduce the volume and area fraction covered by adherent cells (41.42   4.79% and 56.20   9.22% reduction for the Ec5FSL and Ec9FSL biofilms, respectively), and to potentiate the activity of 1n2 MIC FOX in disaggregating biofilms (19.41   7.41% and 34.66   3.75% reduction in the area fraction covered by biofilm for Ec5FSL and Ec9FSL, respectively) and killing cells (36.85 +/- 7.13% and 32.33 +/- 4.65% increase in the biofilm area covered by dead Ec5FSL and Ec9FSL cells, respectively).

The multifunctional role of Poloxamer P338 as a biofilm disrupter and antibiotic enhancer: a small step forward against the big trouble of catheter-associated Escherichia coli urinary tract infections / Henrici De Angelis, Lucia; Stirpe, Mariarita; Tomolillo, Dario; Donelli, Gianfranco; Francolini, Iolanda; Vuotto, Claudia. - In: MICROORGANISMS. - ISSN 2076-2607. - 10:9(2022). [10.3390/microorganisms10091757]

The multifunctional role of Poloxamer P338 as a biofilm disrupter and antibiotic enhancer: a small step forward against the big trouble of catheter-associated Escherichia coli urinary tract infections

Iolanda Francolini
;
2022

Abstract

Poloxamer 338 (P338), a nonionic surfactant amphiphilic copolymer, is herein proposed as an anti-biofilm compound for the management of catheter-associated urinary tract infections (CAUTIs). P338’s ability to disrupt Escherichia coli biofilms on silicone urinary catheters and to serve as antibiotic enhancer was evaluated for biofilm-producing E. coli Ec5FSL and Ec9FSL clinical strains, isolated from urinary catheters. In static conditions, quantitative biofilm formation assay allowed us to determine the active P338 concentration. In dynamic conditions, the BioFlux system, combined with confocal laser scanning microscopy, allowed us to investigate the P338 solution’s ability to detach biofilm, alone or in combination with sub-MIC concentrations of cefoxitin (FOX). The 0.5% P338 solution was able to destroy the structure of E. coli biofilms, to reduce the volume and area fraction covered by adherent cells (41.42   4.79% and 56.20   9.22% reduction for the Ec5FSL and Ec9FSL biofilms, respectively), and to potentiate the activity of 1n2 MIC FOX in disaggregating biofilms (19.41   7.41% and 34.66   3.75% reduction in the area fraction covered by biofilm for Ec5FSL and Ec9FSL, respectively) and killing cells (36.85 +/- 7.13% and 32.33 +/- 4.65% increase in the biofilm area covered by dead Ec5FSL and Ec9FSL cells, respectively).
File allegati a questo prodotto
File Dimensione Formato  
DeAngelis_The-multifunctional_2022.pdf

accesso aperto

Note: full paper
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 7.41 MB
Formato Adobe PDF
7.41 MB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1653175
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact